FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014163375> ?p ?o ?g. }

• W2014163375 endingPage "1193" @default.
• W2014163375 startingPage "1189" @default.
• W2014163375 abstract "In a first experiment, the efficacy of a 6-month course of isoniazid (INH) alone in comparison with 2-month courses of rifampin (RMP) alone, RMP + pyrazinamide (PZA), or RMP+PZA+INH as preventive therapy of tuberculosis was evaluated in the mouse. To simulate the infected, non-diseased state of humans, a nonreplicating bacillary population of limited size was developed in the mouse. Mice were vaccinated intravenously with 2.74 log10 M. bovis BCG and infected a month later with 3.38 log10 M. tuberculosis. Treatment began 2 wk after infection when the mean size of the M. tuberculosis population was 4.98 ± 0.26 log10 cfu in the spleen. After 2 months of therapy, the proportion of mice with positive spleen cultures was 100%, 50%, 0%, and 20% in those animals treated, respectively, with INH alone, RMP alone, RMP+PZA, or RMP+PZA+INH. After 6 months of therapy with INH alone, the proportion of mice with positive spleen cultures was 38%. In order to confirm the extreme activity of the combination RMP+PZA and to assess the value of 3 months of therapy with RMP, a second experiment was performed following similar procedures. On completion of treatment, the proportion of mice with positive spleen cultures was 100%, 20%, 0%, and 80% in those animals treated, respectively, for 6 months with INH alone, 3 months with RMP alone, or 2 months with RMP+PZA, or RMP+PZA+INH. Six months after the end of treatment, the respective proportions of mice with positive spleen cultures were 100%, 60%, 56%, or 95%, suggesting that 2 months of therapy with RMP+PZA or 3 months of therapy with RMP alone were more effective than 6 months of therapy with INH alone." @default.
• W2014163375 created "2016-06-24" @default.
• W2014163375 creator A5020212154 @default.
• W2014163375 creator A5021107240 @default.
• W2014163375 creator A5027073669 @default.
• W2014163375 date "1989-11-01" @default.
• W2014163375 modified "2023-09-25" @default.
• W2014163375 title "Experimental Short-course Preventive Therapy of Tuberculosis with Rifampin and Pyrazinamide" @default.
• W2014163375 cites W1965814419 @default.
• W2014163375 cites W2006786435 @default.
• W2014163375 cites W2058610257 @default.
• W2014163375 cites W2060886162 @default.
• W2014163375 cites W2166431817 @default.
• W2014163375 cites W2327194173 @default.
• W2014163375 cites W4238748109 @default.
• W2014163375 doi "https://doi.org/10.1164/ajrccm/140.5.1189" @default.
• W2014163375 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2817579" @default.
• W2014163375 hasPublicationYear "1989" @default.
• W2014163375 type Work @default.
• W2014163375 sameAs 2014163375 @default.
• W2014163375 citedByCount "144" @default.
• W2014163375 countsByYear W20141633752012 @default.
• W2014163375 countsByYear W20141633752013 @default.
• W2014163375 countsByYear W20141633752014 @default.
• W2014163375 countsByYear W20141633752015 @default.
• W2014163375 countsByYear W20141633752016 @default.
• W2014163375 countsByYear W20141633752017 @default.
• W2014163375 countsByYear W20141633752018 @default.
• W2014163375 countsByYear W20141633752020 @default.
• W2014163375 countsByYear W20141633752021 @default.
• W2014163375 countsByYear W20141633752022 @default.
• W2014163375 countsByYear W20141633752023 @default.
• W2014163375 crossrefType "journal-article" @default.
• W2014163375 hasAuthorship W2014163375A5020212154 @default.
• W2014163375 hasAuthorship W2014163375A5021107240 @default.
• W2014163375 hasAuthorship W2014163375A5027073669 @default.
• W2014163375 hasConcept C126322002 @default.
• W2014163375 hasConcept C142724271 @default.
• W2014163375 hasConcept C203014093 @default.
• W2014163375 hasConcept C2776967927 @default.
• W2014163375 hasConcept C2780459521 @default.
• W2014163375 hasConcept C2780931953 @default.
• W2014163375 hasConcept C2781069245 @default.
• W2014163375 hasConcept C2908647359 @default.
• W2014163375 hasConcept C71924100 @default.
• W2014163375 hasConcept C90924648 @default.
• W2014163375 hasConcept C98274493 @default.
• W2014163375 hasConcept C99454951 @default.
• W2014163375 hasConceptScore W2014163375C126322002 @default.
• W2014163375 hasConceptScore W2014163375C142724271 @default.
• W2014163375 hasConceptScore W2014163375C203014093 @default.
• W2014163375 hasConceptScore W2014163375C2776967927 @default.
• W2014163375 hasConceptScore W2014163375C2780459521 @default.
• W2014163375 hasConceptScore W2014163375C2780931953 @default.
• W2014163375 hasConceptScore W2014163375C2781069245 @default.
• W2014163375 hasConceptScore W2014163375C2908647359 @default.
• W2014163375 hasConceptScore W2014163375C71924100 @default.
• W2014163375 hasConceptScore W2014163375C90924648 @default.
• W2014163375 hasConceptScore W2014163375C98274493 @default.
• W2014163375 hasConceptScore W2014163375C99454951 @default.
• W2014163375 hasIssue "5" @default.
• W2014163375 hasLocation W20141633751 @default.
• W2014163375 hasLocation W20141633752 @default.
• W2014163375 hasOpenAccess W2014163375 @default.
• W2014163375 hasPrimaryLocation W20141633751 @default.
• W2014163375 hasRelatedWork W2012320745 @default.
• W2014163375 hasRelatedWork W2041836958 @default.
• W2014163375 hasRelatedWork W2122649313 @default.
• W2014163375 hasRelatedWork W2209100444 @default.
• W2014163375 hasRelatedWork W2380824164 @default.
• W2014163375 hasRelatedWork W2412055222 @default.
• W2014163375 hasRelatedWork W2412864285 @default.
• W2014163375 hasRelatedWork W2413049982 @default.
• W2014163375 hasRelatedWork W3042910603 @default.
• W2014163375 hasRelatedWork W4301718791 @default.
• W2014163375 hasVolume "140" @default.
• W2014163375 isParatext "false" @default.
• W2014163375 isRetracted "false" @default.
• W2014163375 magId "2014163375" @default.
• W2014163375 workType "article" @default.